Element AVITI vs Illumina NovaSeq X
Since April 2025, 447 bioRxiv and medRxiv preprints say they used AVITI and 3,525 NovaSeq X; 56 used both. Updated daily (as of Nov 16)
NovaSeq X is used 8x more often than AVITI.
In Jun–Nov 2026, 1,309 preprints said they used Illumina NovaSeq X, and 171 Element AVITI.
AVITI and NovaSeq X are growing at about the same pace.
In Jun–Nov 2026 vs the previous year, as a share of all preprints, Element AVITI grew 50% and Illumina NovaSeq X grew 47%.
AVITI
NovaSeq X
The last bar is the quarter so far.
Which preprints have used both Element AVITI and Illumina NovaSeq X?
56 preprints since April 2025 say they used both Element AVITI and Illumina NovaSeq X. That's 13% of the 447 preprints using AVITI and 2% of the 3,525 using NovaSeq X.
Latest preprints using AVITI
Latest preprints using NovaSeq X
Which institutions use Element AVITI and Illumina NovaSeq X most?
Labs at University of Lausanne, Columbia University and École Polytechnique Fédérale de Lausanne use Element AVITI most; at Stanford University, University of California, San Francisco and University of California, Los Angeles, Illumina NovaSeq X. The lab's institution is the corresponding author's.
AVITI Element Biosciences
Where the labs are
Institutions using it most
University of Lausanne18
Columbia University16
École Polytechnique Fédérale de Lausanne12
University of California, Davis12
Fields
Genomics 73Microbiology 68Molecular biology 40Cancer biology 30
NovaSeq X Illumina
Where the labs are
Institutions using it most
Stanford University92
University of California, San Francisco61
University of California, Los Angeles53
University of California, San Diego51
Fields
Genomics 406Microbiology 395Cancer biology 323Neuroscience 316
How we count which preprints use each platform
An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. This page counts how often each platform is used in preprints. It does not show which is better, or market share. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.